Диссертация (1174270), страница 34
Текст из файла (страница 34)
Theobald, K. Lääne, Y. Peña, E.R. Murphy, Y. Shah, K. Probst, I.Abakumova, F.I. Aigbirhio, H.K. Richards, Y. Hong, J.C. Baron, B.J. Everitt,T.W. Robbins // Science. – 2007. – V. 315. - №5816. – P. 1267-1270.87.Dang, D. The emergence of devastating impulse control disorders duringdopamine agonist therapy of the restless legs syndrome / D. Dang, D.Cunnington, J. Swieca // Clin Neuropharmacol. – 2011. – V.
34. - №2. – P. 6670.88.Day, J. Cholinergic activity in the rat hippocampus, cortex and striatumcorrelates with locomotor activity: an in vivo microdialysis study / J. Day, G.Damsma, H.C. Fibiger // Pharmacol. Biochem. Behav. – 1991. – V. 38. - №4. –P. 723-729.89.De Chazeron I. Hypersexuality and pathological gambling in Parkinson’sdisease: A cross-sectional case-control study / I. de Chazeron, P.M. Llorca, I.Chéreau-Boudet, O.
Blanc, J. Perriot, L. Ouchchane, M. Ulla, B. Debilly, P.Derost, F. Durif // Movement Disorders. - 2011. - V. 26. - №11. - P. 2127-30.19790.Di Matteo, V. Serotonin modulation of the basal ganglia circuitry: Therapeuticimplication for Parkinson’s disease and other motor disorders / V.
Di Matteo, M.Pierucci, E. Esposito, G. Crescimanno, A. Benigno, G. Di Giovanni // Prog BrainRes. - 2008. – V.172. – P. 423-463.91.Djamshidian, A. Pathological gambling in Parkinson's disease—a review of theliterature / A. Djamshidian, F. Cardoso, D. Grosset, H.
Bowden-Jones, A.J. Lees// Mov Disord. – 2011. – V. 26. - № 11. - P. 1976-84.92. Duan, J.Synonymous mutations in the human dopamine receptor D2 (DRD2)affect mRNA stability and synthesis of the receptor / J. Duan, M.S. Wainwright,J.M. Comeron, N. Saitou, A.R. Sanders, J. Gelernter, P.V. Gejman // Hum MolGenet.
- 2003. V.12. - №3.- P. 205-216.93.Dubois, B. Cognitive deficits in Parkinson’s disease / B. Dubois, B. Pillon //Journal of Neurology. – 1997. – V.244. - №1. – P. 2-8.94. Egan, M.F. The BDNF val66met polymorphism affects activity-dependentsecretion of BDNF and human memory and hippocampal function / M.F. Egan,M. Kojima, J.H. Callicott, T.E. Goldberg, B.S. Kolachana, A. Bertolino, E.Zaitsev, B. Gold, D. Goldman, M. Dean, B.
Lu, D.R. Weinberger // Cell. – 2003.– V.112. - №2. – P. 257-269.95.Ellinwood, E.H. Evolving behavior in the clinical and experimentalamphetamine (model) psychosis / E.H. Ellinwood, A. Sudilovsky, L.M. Nelson //Am J Psychiatry. – 1973.- V.130. - №10. – P. 1088–1093.96.Ellinwood, M.D. Amphetamine psychosis: a multi-dimensional process / M.D.Ellinwood // Semin Psychiatry.
– 1969. – V.1. – P. 208–22.97.Ephraty, L. Neuropsychiatric and cognitive features in autosomal-recessive earlyparkinsonism due to PINK1 mutations / L. Ephraty, O. Porat, D. Israeli, O.S.Cohen, O. Tunkel, S. Yael, Y. Hatano, N. Hattori, S. Hassin-Baer // Mov Disord.– 2007. – V. 22. - №4. – P.
566–569.98. Evans, A.H. Dopamine dysregulation syndrome in Parkinson's disease / A.H.Evans, A.J. Lees // Curr Opin Neurol. – 2004. – V. 17. - № 4. – P. 393-398.19899.Evans, A.H. Compulsive drug use linked to sensitized ventral striatal dopaminetransmission / A.H. Evans, N. Pavese, A.D. Lawrence, Y.F. Tai, S. Appel, M.Doder, D.J. Brooks, A.J.
Lees, P. Piccini // Annals of Neurology. – 2006. – V.59.- №5. – P. 852-858.100.Evans, A.H. Factors in fluencing susceptibility to compulsive dopaminergicdrug use in Parkinson’s disease / A. H. Evans, A. D. Lawrence, J. Potts, S.Appel, A. J. Lees // Neurology. – 2005. – V.65. - №10. – P.
1570–1574.101.Evans, A.H. Punding in Parkinson’s disease: Its relation to the dopaminedysregulation syndrome / A.H. Evans, R. Katzenschlager, D. Paviour, J.D.O’Sullivan, S. Appel, A.D. Lawrence, A.J. Lees // Mov Disord. – 2004. – V.19. №4. – P. 397-405.102.Fahn, S. Unified Parkinson’s disease rating scale. In: S Fahn, C.D.Marsden, D. Calne, M Goldstein, eds. Recent developments in Parkinson’sdisease. Florham Park, NJ: Macmillan Healthcare Information.
– 1987. – P.153—163.103.Falcón, E. A role for the circadian genes in drug addiction / E. Falcón, C.A.McClung // Neuropharmacology. – 2009. – V.56. – Suppl. 1. – P. 91–96.104.Fan, W. Impulse control disorders in Parkinson's disease in a Chinesepopulation / W. Fan, Y. Ding, J. Ma, P. Chan // Neurosci Lett. – 2009.
– V.465. №1. – P. 6–9.105.Fanghanel, G. Neurosurgery in feeding disorders: a possible option? / G.Fanghanel, L. Sanchez-Reyes, A. Madrigal et al. // Salud mental. – 2011. – V.9. №1ю – P. 28-34.106.Fantini, M.L. Increased risk of impulse control symptoms in Parkinson'sdisease with REM sleep behaviour disorder / M.L. Fantini, L. Macedo, M.Zibetti, M. Sarchioto, T. Vidal, B. Pereira, A.
Marques, B. Debilly, P. Derost, M.Ulla, N. Vitello, A. Cicolin, L. Lopiano, F. Durif // J Neurol NeurosurgPsychiatry. – 2014. – V. 86. - №2. – P. 174-9.107.Fantini, M.L. Sleep and REM sleep behaviour disorder in Parkinson’sdisease with impulse control disorder / M.L. Fantini, M. Figorilli, I. Arnulf, M.199Zibetti, B. Pereira, P.
Beudin, M. Puligheddu, F. Cormier-Dequaire, L.Lacomblez, E. Benchetrit, J.C. Corvol, A. Cicolin, L. Lopiano, A. Marques, F.Durif // J Neurol Neurosurg Psychiatry. – 2017. – V. 89. - № 3. – P. 305-310.108.Fasano, A. Punding and computer addiction in Parkinson’s disease / A.Fasano, A.E. Elia, F. Soleti, A. Guidubaldi, A.R.
Bentivoglio // Mov. Disord. –2006. – V.21. - №8. – P. 1217–1218.109.Favorov, A.V. A Markov chain Monte Carlo technique for identification ofcombinations of allelic variants underlying complex diseases in humans / A.V.Favorov, T.V. Andreewski, M.A. Sudomoina, O.O. Favorova, G. Parmigiani,M.F. Ochs / Genetics. - 2005. - V.171. - №4.- P.2113-2121.110.Fernandez, H.H. Punding on L-dopa / H.H. Fernandez, J.H. Friedman //Mov. Disord.
– 1999. – V. 14. – №5. - P. 836–838.111.Folstein, M.F. «Mini-mental state». A practical method for grading thecognitive state of patients for the cliniciaт // M.F. Folstein, S.E. Folstein, P.R.McHugh. Journal of psychiatric research. – 1975. – V.12. -№3. – P. 189–98.112.Foltynie, T. The BDNF Val66Met polymorphism has a gender specificinfluence on planning ability in Parkinson’s disease / T.
Foltynie, S. G. Lewis, T.E. Goldberg, A.D. Blackwell, B.S. Kolachana, D.R. Weinberger, T.W. Robbins,R.A. Barker // Journal of Neurology. – 2005. – V.252. - №7. – P. 833–838.113.Friedman, J.H. Punding on levodopa / J.H. Friedman // Biol Psychiatry. –1994. – V.36. - №5. – P.
350– 351.114.Frosini, D. Parkinson’s disease and pathological gambling: Results from afunctional MRI study / D. Frosini, I. Pesaresi, M. Cosottini, G. Belmonte, C.Rossi, L. Dell’Osso, L. Murri, U. Bonuccelli, R. Ceravolo // MovementDisorders. – 2010. – V.25.
- №14. – P. 2449-2453.115.Gallagher, D.A. Pathological gambling in Parkinson’s disease: risk factorsand differences from dopamine dysregulation. An analysis of published caseseries / D.A. Gallagher, S.S. O’Sullivan, A.H. Evans, A.J. Lees, A. Schrag //Movement Disorders. – 2007. – V.22. - №12. – P. 1757–1763.200116.García Ruiz, PJ. Efficacy of long-term continuous subcutaneousapomorphine infusion in advanced Parkinson's disease with motor fluctuations:A multicenter study / P.J. García Ruiz, A. Sesar Ignacio, B. Ares Pensado, A.Castro García, F. Alonso Frech, M. Alvarez López, J. Arbelo González, J.
BaigesOctavio, J.A. Burguera Hernández, M. Calopa Garriga, D. Campos Blanco, B.Castaño García, M. Carballo Cordero, J. Chacón Peña, A. Espino Ibáñez, A.Gorospe Onisalde, S. Giménez-Roldán, P. Granés Ibáñez, J. Hernández Vara, R.Ibáñez Alonso, F.J. Jiménez Jiménez, J. Krupinski, J. Kulisevsky Bojarsky, I.Legarda Ramírez, E. Lezcano García, J.C.
Martínez-Castrillo, D. MateoGonzález, F. Miquel Rodríguez, P. Mir, E. Muñoz Fargas, J. Obeso Inchausti, J.Olivares Romero, J. Olivé Plana, P. Otermin Vallejo, B. Pascual Sedano, V.Pérez de Colosía Rama, I. Pérez López-Fraile, A. Planas Comes, V. PuentePeriz, M.C. Rodríguez Oroz, D.
Sevillano García, P. Solís Pérez, J. SuárezMuñoz, J. Vaamonde Gamo, C. Valero Merino, F. Valldeoriola Serra, J.M.Velázquez Pérez, R. Yáñez Baña, I. Zamarbide Capdepon // Mov Disord. – 2008.– V.23. - №8. – P. 1130-6.117.Garcia-Ruiz, P. Impulse control disorders in patients with Parkinson’sdisease under dopamine agonist therapy: a multicentre study / P.J. Garcia-Ruiz,J.C. Martinez Castrillo, A.
Alonso-Canovas, A. Herranz Barcenas, L. Vela, P.Sanchez Alonso, M. Mata, N. Olmedilla Gonzalez, I. Mahillo Fernandez // JNeurol Neurosurg Psychiatry. – 2014. – V.8. - №8. – P.840-4.118.Ghosh, S. Noradrenaline vs terlipressin in the treatment of type 2hepatorenal syndrome: a randomized pilot study / S. Ghosh, N.S. Choudhary, A.K. Sharma, B. Singh, P. Kumar, R. Agarwal, N. Sharma, A. Bhalla, Y. K.Chawla, V. Singh // Liver Int.
– 2013. – V.33. – №8. - P. 1187–1193.119.Gibb, W.R. Accuracy in the clinical diagnosis of parkinsonian syndromes /W.R. Gibb // Postgrad Med J. – 1988. – V. 64. - № 751. – P. 345-51.120.Giladi, N. New onset heightened interest or drive for gambling, shopping,eating or sexual activity in patients with Parkinson's disease: the role ofdopamine agonist treatment and age at motor symptoms onset / N. Giladi, N.201Weitzman, S. Schreiber, H.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
